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nnexins are Ca
 
2
 

 
-binding, membrane-fusogenic pro-
teins with diverse but poorly understood functions.
Here, we show that during cell cycle progression
annexin 11 translocates from the nucleus to the spindle
poles in metaphase and to the spindle midzone in anaphase.
Annexin 11 is recruited to the midbody in late telophase,
where it forms part of the detergent-resistant matrix that
also contains CHO1. To investigate the significance of
these observations, we used RNA interference to deplete
cells of annexin 11. A combination of confocal and video
A
 
time-lapse microscopy revealed that cells lacking annexin
11 fail to establish a functional midbody. Instead, daughter
cells remain connected by intercellular bridges that contain
bundled microtubules and cytoplasmic organelles but
exclude normal midbody components such as MKLP1 and
Aurora B. Annexin 11–depleted cells failed to complete
cytokinesis and died by apoptosis. These findings demon-
strate an essential role for annexin 11 in the terminal phase
of cytokinesis.
 
Introduction
 
Annexin 11 is one of a large family of calcium-dependent
phospholipid-binding proteins with roles in calcium signaling,
apoptosis, and vesicle trafficking (for review see Gerke and
Moss, 2002). Annexins appear to be present in all eukaryotic
phyla except yeasts, and most mammalian cell types express
a subset of family members. Of the dozen vertebrate family
members, annexin 11 is believed to be the most evolution-
arily ancient (Fernandez et al., 1996; Morgan et al., 1998).
Like all annexins, it contains multiple tandem repeats of a
70–amino acid domain in which the Ca
 
2
 

 
-binding sites are
located, but in common only with annexin 7, it has a long
NH
 
2
 
 terminus rich in glycine, proline, and tyrosine residues
(Tokumitsu et al., 1992; Towle and Treadwell, 1992).
Annexin 11 is ubiquitously expressed and has been identified
in the nucleus in most cultured cell lines studied (Mizutani et
al., 1992; Farnaes and Ditzel, 2003; Tomas and Moss, 2003).
Despite the absence of a recognizable nuclear localization
signal in the NH
 
2
 
 terminus, mutagenesis experiments have
identified this domain as being required for targeting of
annexin 11 to the nucleus (Mizutani et al., 1995).
The NH
 
2
 
-terminal domain of annexin 11 has also been
shown to contain the binding sites for at least two intracellular
polypeptide ligands, namely calcyclin (S100A6) and the
apoptosis-linked protein ALG-2 (Tokumitsu et al., 1993; Satoh
et al., 2002). In both cases, the interaction between annexin 11
and its ligand has been shown in in vitro experiments to be
Ca
 
2
 

 
 dependent, but neither the purpose of the interaction nor
indeed the function of either of the participating proteins is
known. The differential expression of calcyclin during the cell
cycle (Calabretta et al., 1986) and evidence that annexin 11
may have a role both in mitosis (Mizutani et al., 1992) and in
nuclear envelope dynamics during prophase (Tomas and Moss,
2003) prompted us to examine more closely the subcellular
localization of annexin 11 during the different stages of cell
division. We show here that from late mitosis through to cyto-
kinesis, annexin 11 colocalizes with established components of
the central spindle and midbody, such as CHO1 and the Au-
rora B kinase. Furthermore, in experiments using siRNA we
show that cells depleted of annexin 11 do not present a mid-
body matrix at the middle of the central spindle, and subse-
quently undergo abortive cell separation in which daughter
cells remain connected by bridgelike cytoplasmic structures
and ultimately die by apoptosis. These results demonstrate an
essential function for annexin 11 in the last phase of cytokinesis.
 
Results
 
The localization of annexin 11 is regulated during 
the cell cycle
 
To find out if the subcellular localization of annexin 11 is
regulated during cell division, we used confocal immunoflu-
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orescence microscopy to track annexin 11 through the late
stages of the cell cycle in conjunction with 
 

 
-tubulin in
A431 cells (Fig. 1 A). From the nucleus of interphase cells
(unpublished data), annexin 11 partially relocates to the de-
generating nuclear envelope during prophase, which is con-
sistent with our previous findings (Tomas and Moss, 2003).
In metaphase, annexin 11 is distributed throughout the cell
but with greatest intensity at the mitotic half-spindles, also
consistent with a recent paper describing colocalization of
annexin 11 and 
 

 
-tubulin in COS-7 cells (Farnaes and Dit-
zel, 2003). As the chromosomes segregate during anaphase,
annexin 11 concentrates along the central spindle, eventu-
ally becoming focused at the midzone and ultimately in the
midbody at cytokinesis. The specificity of the antisera used
in these experiments was demonstrated by pre-adsorption of
the primary antibody with affinity-purified annexin 11 pro-
tein before immunostaining (Fig. 1 B), and the localization
of annexin 11 at the midbody was confirmed by costaining
with antisera to the cytokinesis-associated protein kinase Au-
rora B (Terada et al., 1998; Fig. 1 C).
To exclude the possibility that these observations were a
peculiarity of A431 cells, we immunostained HeLa and
HEp2 cells in cytokinesis (Fig. 2 A). These cells also re-
vealed annexin 11 at the midbody as well as in the regen-
erating nuclear envelope in HEp2. In higher resolution
images of A431, HeLa, and HEp2 cells, annexin 11 immu-
noreactivity at the midbody had the appearance of two par-
allel discs positioned at the center of and perpendicular to
the central spindle, which persisted as part of the midbody
remnant that connects two daughter cells after furrow in-
gression is completed (Piel et al., 2001; Fig. 2, B–D). Al-
though the annexin 11 discs appear to “cap” the facing ends
of the microtubule bundles at these extreme late stage mid-
bodies, the staining probably defines the lateral borders of
the midbody matrix.
To explore the relationship between annexin 11 and mid-
body formation in greater detail, A431 cells were blocked
at prometaphase with nocodazole, and then released into
brefeldin A (BFA). In 
 
Caenorhabditis elegans
 
, BFA has been
shown to disrupt the terminal phase of cytokinesis, most
likely by inhibiting the targeted secretion of membrane vesi-
cles to the late cleavage furrow (Skop et al., 2001). Consis-
tent with these observations, A431 cells furrowed normally
in the presence of BFA (Fig. 2 E), but then became binucle-
ate after the failure of the terminal phase of cytokinesis (Fig.
2 F). In the presence of BFA, the staining intensity for an-
nexin 11 at the midbody was increased and concentrated in
a disc concentric to the actomyosin contraction ring and
spanning its internal diameter (Fig. 2 G). Therefore, the lo-
calization of annexin 11 to the midbody proved to be BFA
insensitive, suggesting that annexin 11 is not a component
of the membrane vesicles targeted to the midbody but a con-
stituent of the midbody matrix. This idea was further sup-
ported in BFA-treated cells costained for annexin 11 and the
Golgi marker GM130, in which the Golgi-derived vesicles,
thought to be the source of membrane targeted to the cleav-
age furrow during the terminal phase of cytokinesis (Hill et
al., 2000; Lecuit and Wieschaus, 2000), did not costain for
annexin 11 (Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200311054/DC1).
Figure 1. Immunolocalization of annexin 11 at the different stages 
of the cell cycle. (A) A431 cells were fixed at different stages of 
cell cycle progression and stained for -tubulin and annexin 11. 
Annexin 11 is predominantly localized to the nucleoplasm and 
nuclear envelope during NEB (prophase, arrows), with enrichment 
toward the centrosomes and the spindle in metaphase (open arrow-
heads). In anaphase and telophase, annexin 11 concentrates in 
the midzone region (closed arrowheads) with intense staining at the 
midbody during cytokinesis. (B) Control experiment showing A431 
cells at cytokinesis immunostained for -tubulin and annexin 11, 
but with the latter antibody pre-adsorbed with affinity-purified GST-
annexin 11. The arrow in the merged image points to the absence 
of annexin 11 immunoreactivity at the midbody. (C) A431 cells at 
cytokinesis were fixed and immunostained as in B for annexin 11 
and the kinase Aurora B. The merged image (right) shows colocal-
ization of annexin 11 and Aurora B at the midbody (arrowhead).
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Annexin 11 associates with midbody components 
during cytokinesis
 
The staining pattern of annexin 11 from anaphase to cytoki-
nesis bears striking similarities to that reported for the mi-
totic kinesin-like protein CHO1, an alternatively spliced
product of the 
 
MKLP1
 
 gene with essential roles in the main-
tenance of the microtubule bundles at the central spindle
and in the organization of the midbody matrix (Matuliene
and Kuriyama, 2002). To further investigate a possible rela-
tionship between these two proteins, we examined their lo-
calization in A431 cells at various times in the cell cycle (Fig.
3 A). Although annexin 11 and CHO1 are predominantly
nuclear in interphase and metaphase cells, there is no tight
colocalization at this time. However, from anaphase through
to cytokinesis, and at the midbody, there is marked colocal-
ization of annexin 11 and CHO1. Both proteins are also
highly enriched in isolated midbodies (Fig. 3 B). This find-
ing is consistent with previous reports for CHO1 (Sellitto
and Kuriyama, 1988) and indicates that the association of
annexin 11 with this structure is stable.
CHO1 has previously been shown to physically interact
with microtubules (Kuriyama et al., 1994), F-actin (Kuri-
yama et al., 2002), and the small G-protein Arf3 (Boman et
al., 1999). We performed pull-down experiments to in-
vestigate whether tubulin or CHO1 also associate with an-
nexin 11. A431 cells were either collected immediately after
prometaphase block or further treated with BFA and col-
lected at cytokinesis, the latter resulting in an enrichment of
annexin 11 at the midbody. Under these cell lysis condi-
tions, and regardless of whether cells were extracted at
prometaphase or cytokinesis, 
 

 
90% of annexin 11 appeared
in the soluble fraction (Fig. 3 C). Immunoprecipitation of
annexin 11 from the postnuclear supernatants resulted in
the sequestration of 
 

 
70% of the solubilized fraction. West-
ern blotting revealed the presence of CHO1 in immunopre-
cipitates of annexin 11 specifically during late mitosis
and cytokinesis, whereas tubulin was present in both
prometaphase- and cytokinesis-derived immune complexes
(Fig. 3 D). A mock immunoprecipitation using control goat
IgG in place of anti–annexin 11 failed to yield CHO1 upon
Western blotting though tubulin was detected, suggesting
that although the presence of CHO1 in the annexin 11 im-
munoprecipitates reflects a specific interaction, the tubulin
may be at least to some extent a contaminant. The control
blot (Fig. 3 D) confirms approximately equal band intensi-
ties for annexin 11 in the immunoprecipitates. Western
blotting of whole cell lysates prepared from cells synchro-
nized at prometaphase and cytokinesis revealed bands of
equal intensities for CHO1, tubulin, and annexin 11 (Fig. 3
E), confirming that the presence of CHO1 in the annexin
Figure 2. Annexin 11 is a component 
of the midbody in different cell lines. 
(A) HeLa and HEp2 cells were fixed in 
cytokinesis and stained for annexin 11. 
The pink arrowheads indicate annexin 
11 at the midbody, whereas the yellow 
arrowheads highlight the localization of 
annexin 11 to the reforming nuclear 
envelope in the daughter HEp2 cells. 
A431 (B), HeLa (C), and HEp2 (D) cells 
were fixed in cytokinesis and stained for 
annexin 11 and -tubulin. In B, C, and 
D, annexin 11 is organized as two parallel 
discs at either side of the midbody 
remnant (arrowheads), perpendicular 
to the central spindle. (E and F) A431 
cells were blocked in prometaphase 
with nocodazole, followed by treatment 
with BFA for 1–3 h. Cells were subse-
quently fixed and stained for -tubulin 
and DNA (with propidium iodide; F). 
After 1 h of BFA treatment (E), 20% of 
the cells were in late anaphase or telo-
phase (yellow arrowheads). After 3 h of 
treatment (F), numerous binucleate cells 
were detected among the recently divided 
cells (white arrows). For quantitative 
evaluation of the effects of BFA, A431 
cells were synchronized with thymidine 
overnight, incubated for 6 h in nocoda-
zole, and then released for 3 h in the 
presence or absence of BFA. Cells were 
fixed and stained for -tubulin and 
DNA with DAPI. Binucleate and total 
cell counts were performed. Results are 
the average of five counts from two 
different Petri dishes. (G) Synchronized and BFA-treated A431 cells were fixed and stained for annexin 11 and for F-actin (with TRITC-phalloidin). 
The image shows a cell in cytokinesis and a zoom-in across the cleavage furrow. Annexin 11 is located in the midbody at the center of the 
actomyosin constriction ring formed at the furrow.
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11 immunoprecipitates at cytokinesis does not simply reflect
increased cellular levels of CHO1 at this point in the cell cy-
cle. Together, these results show that annexin 11 indeed in-
teracts (directly or indirectly) with CHO1 during cytokine-
sis, and support the idea that annexin 11 and CHO1 are
constituents of a midbody multiprotein complex.
 
Annexin 11 knockdown inhibits completion 
of cytokinesis and leads to apoptosis
 
To investigate the role of annexin 11 in cytokinesis, we used
RNA interference (RNAi) to depress the level of annexin 11
in A431 and HeLa cells. Incubation with a 21-base pair
RNA duplex corresponding to nucleotides gACggCTTACg-
gCAAggAT of annexin 11 led to a time-dependent decrease
in the levels of annexin 11 protein and mRNA (Fig. 4, A
and B), although the kinetics of annexin 11 depletion ap-
peared more rapid in A431 cells. In HeLa cells, after two
rounds of transfection over 6 d, annexin 11 was barely de-
tectable by Western blotting or RT-PCR, whereas closely re-
lated molecules such as annexin 1 and annexin 5 were un-
changed. Immunofluorescence analysis of HeLa cells after
5 d in annexin 11 siRNA revealed the absence of detectable
annexin 11 staining in the nucleus, with residual punctate
annexin 11 staining in the cytoplasm (Fig. 4 C). These re-
sults demonstrate the efficacy and specificity of siRNA-
mediated suppression of annexin 11 expression in this ex-
perimental system.
To investigate the annexin 11 null phenotype in greater
detail, we cultured HeLa and A431 cells for 2 d in an-
nexin 11 siRNA and analyzed them by immunofluores-
cence. HeLa cells undergoing cytokinesis appeared to furrow
normally but lacked the dense material located in the middle
of the central spindle corresponding to the midbody matrix
(Fig. 5 A). The absence of the midbody matrix is clear when
contrasted against control cells in which the immunostain-
ing for 
 

 
-tubulin is completely missing from the equator of
the central spindle due to the inability of the antibody to ac-
cess the microtubules through the matrix (Matuliene and
Kuriyama, 2002; Fig. 5 B). Confocal microscopy of fixed
A431 cells immunostained for 
 

 
-tubulin revealed that de-
Figure 3. Annexin 11 colocalizes and interacts with CHO1 at cytokinesis. (A) A431 cells were synchronized in mitosis and fixed and stained 
for annexin 11 and CHO1. DNA was labeled with propidium iodide. Cells in interphase through to cytokinesis are depicted. Both annexin 11 
and CHO1 are located mainly inside the nucleus during interphase and are excluded from the nucleoli. During metaphase, CHO1 relocates 
along the spindle while annexin 11 is dispersed throughout the cell, though with some enrichment at the spindle. From anaphase onwards, 
both proteins extensively colocalize, first at the central spindle, then at the midzone, and ultimately in the midbody during cytokinesis (arrows). 
(B) A431 cells were synchronized and collected in cytokinesis. Midbodies were isolated as described in Materials and methods, adsorbed 
onto polylysine-coated coverslips, and stained for annexin 11 (green), -tubulin (blue), and CHO1 (red). CHO1 and annexin 11 intensely 
colocalize at the center of the isolated midbody. (C) A431 cells were synchronized at prometaphase and cytokinesis and solubilized in lysis 
buffer (see Materials and methods for details). The lysate was centrifuged and the post-nuclear supernatant (S/N) and pellet were resolved by 
SDS-PAGE and probed for annexin 11 by immunoblotting. After immunoprecipitation, the post IP supernatant was also immunoblotted to 
evaluate the degree of immunodepletion. (D) A431 cells were synchronized at prometaphase, and either harvested immediately or incubated 
in BFA for 1 h and collected in cytokinesis. Cells were lysed, and annexin 11 was immunoprecipitated and resolved by SDS-PAGE. After Western 
blotting, filters were probed for CHO1, -tubulin, and annexin 11 (to confirm equal loadings). The two bottom panels show blots for CHO1 
and -tubulin after mock immunoprecipitation using a control goat IgG. (E) A431 cells were synchronized at prometaphase or cytokinesis as 
in C, and whole cell lysates were resolved by SDS-PAGE followed by Western blotting for CHO1, -tubulin, and annexin 11.
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pletion of annexin 11 similarly leads to failure to establish a
midbody matrix and accumulation of microtubule bundles
(Fig. 5 C), where the matrix is normally located in control
cells (Fig. 5 D). Electron microscopy of annexin 11–depleted
A431 cells confirms that midbodies fail to form and shows
that microtubule bundles and endoplasmic reticulum are
distributed throughout the area where the midbody would
normally form (Fig. 6). These results show that in distinct
cell types annexin 11 is required for formation of the mid-
body matrix.
To examine the effects of annexin 11 depletion on the dis-
tribution of established midbody proteins, we immuno-
stained A431 cells undergoing abortive cytokinesis for
MKLP1 and Aurora B kinase. As expected, in control cells
MKLP1 localized predominantly to the midbody in cells at
cytokinesis (Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200311054/DC1). However, in cells de-
pleted of annexin 11 that fail to form a midbody, MKLP1
remained concentrated in the daughter nuclei, which is con-
sistent with its localization in normal interphase cells (Chen
et al., 2002). The apparent failure of MKLP1 to exit the nu-
cleus is consistent with an essential role for annexin 11 in the
recruitment of midbody proteins and midbody assembly,
though it is also possible that MKLP1 targets correctly in
late telophase and then regresses to the nucleus when cytoki-
nesis fails. In contrast, Aurora B was concentrated at the lat-
eral borders of the midbody in control A431 cells at cytoki-
nesis, but was expressed along the full length of the extended
intracellular cytoplasmic bridge in annexin 11–depleted cells
(Fig. S2). Although Aurora B has not yet been ascribed a
role at the midbody, the modest effect of annexin 11 deple-
tion on Aurora B localization is consistent with annexin 11
having a function in cytokinesis that lies temporally down-
stream of the known role of Aurora B in spindle assembly
and chromosome segregation.
Phase-contrast time-lapse imaging revealed marked differ-
ences between control and annexin 11 siRNA-treated A431
cells undergoing cytokinesis (Fig. 7, A and B; and Videos
1 and 2, available at http://www.jcb.org/cgi/content/full/
jcb.200311054/DC1). Depletion of annexin 11 resulted in
a highly abnormal cellular morphology characterized by cell
bodies connected by long cytoplasmic bridgelike extensions.
The images of live cells entering cytokinesis show that al-
though furrowing progresses normally in annexin 11–
depleted cells, abscission does not occur (Fig. 7 B). Instead,
the daughter cells become separated by increasingly thin
cytoplasmic extensions, a process that is accompanied by
rounding up of the optically refractive cell bodies, eventual
detachment from the surface of the coverslip, and cell death.
To extend these observations to a large cell population, we
performed flow cytometry on A431 cells at various stages of
culture in annexin 11 siRNA (Fig. 7 C). By measuring for-
ward scatter, we observed an increase in cell length at days
two and three, corresponding to the peak period of abortive
cytokinesis, after which cell/particle size diminished as the
cells died and fragmented.
To test whether or not the cell death that we observed in
the RNAi experiments was apoptotic, we performed a PARP
immunoblot on cells after annexin 11 depletion. This exper-
iment revealed the presence of cleaved PARP in annexin 11
siRNA-treated A431 cells (Fig. 7 D), which was indicative of
caspase activation and apoptosis (Scovassi and Poirier,
1999). In HeLa and A431 cells cultured in siRNA for an-
nexin 11, stained with propidium iodide, and analyzed by
flow cytometry, we observed a decrease in 2n and 4n peaks
through day three to five after transfection, together with a
concomitant increase in the sub-2n nuclear pool, a further
diagnostic feature of apoptosis (Fig. 7, E–G). Cells cultured
in siRNA for annexin 5 showed no such changes. By day
four of annexin 11 siRNA treatment in A431 cells, and by
day six in HeLa cells, we observed 
 

 
70% apoptotic cell
death (Fig. 7 F) as judged by quantification of the flow cy-
tometry data, by which time cells also exhibited the typical
morphological blebbing associated with apoptosis (not
depicted).
 
Discussion
 
We have shown here that annexin 11, a predominantly nu-
clear protein during interphase, exhibits a tightly regulated
pattern of localization during the latter stages of the cell cy-
cle from prophase to cytokinesis. This pattern is typical of
several midbody proteins, and we show that annexin 11
tracks especially closely with the mitotic kinesin-like pro-
tein CHO1 (Matuliene and Kuriyama, 2002). Because
Figure 4. Depletion of annexin 11 using siRNA. (A) A431 cells were 
treated with siRNA for annexin 11, with oligofectamine alone (of) 
or with no additives (wt) for the periods indicated. Whole cell lysates 
were resolved by SDS-PAGE and immunoblotted for annexin 11 
and -tubulin. Note that the level of annexin 11 drops after 2 d of 
siRNA treatment. (B) HeLa cells were cultured in 24-well plates and 
treated with siRNA. Cells were lysed after 5 and 6 d of treatment 
and analyzed by Western blotting and RT-PCR. Note that the levels 
of annexin 11 cDNA and protein are significantly decreased by day 
five, whereas the levels of annexins 1 and 5 remain unchanged. 
(C) HeLa cells were treated for 5 d with siRNA specific for annexin 
11 or 5 (control), and then fixed and stained for annexin 11, -tubulin, 
and DNA (with propidium iodide). Note that the green fluorescence 
corresponding to annexin 11 is still present in cells treated with 
annexin 5 siRNA, but is significantly diminished in cells treated with 
annexin 11 siRNA.
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CHO1 has been reported to engage in interactions with
microtubules, F-actin, and Arf3, we investigated the possi-
bility that annexin 11 may also form part of what appears
to be a midbody multiprotein complex. Coimmunoprecip-
itation experiments revealed that annexin 11 and CHO1
not only become enriched at the midbody but also physi-
cally associate, either directly or indirectly, from late mito-
sis through to cytokinesis. This association appears to be
specific for this stage of the cell cycle, as it is not present in
nocodazole-treated cells blocked at prometaphase. Like
Figure 5. Annexin 11 is required for midbody matrix formation. 
(A) HeLa cells treated with annexin 11 siRNA for 2 d were fixed and stained 
for lamin B and -tubulin. DNA was labeled using propidium iodide. 
The merged image shows an intact microtubular bridge between the two 
daughter nuclei, but with no midbody matrix (arrowhead). (B) HeLa cells 
were synchronized, fixed in cytokinesis, and stained for -tubulin. In three representative cells, the midbody matrix (arrowheads) is clearly 
visible as a narrow band from which -tubulin staining is excluded. (C) A431 cells were treated with annexin 11 siRNA and fixed and stained 
after 2 d for -tubulin and DNA as in A. Two examples show an abnormal enrichment of -tubulin at the midbody center (yellow arrowhead) 
and failure to establish a midbody matrix (white arrowhead). (D) Control A431 cells fixed and immunostained at cytokinesis reveal exclusion 
of -tubulin staining at the midbody matrix, as observed in B for HeLa cells.
Figure 6. Electron microscopy shows 
a complete absence of midbody forma-
tion in annexin 11–depleted cells. 
A431 cells were treated with annexin 11 
siRNA for 3 d, and were then fixed and 
processed for electron microscopy. Low 
magnification view (A) shows a cytoplas-
mic bridge between adjacent cell bodies. 
The area indicated is enlarged in B to 
show the absence of a midbody and 
the distribution of microtubule bundles 
(arrows) and endoplasmic reticulum 
(arrowheads) throughout the area where 
the midbody would normally form. 
Bars, 1 m.
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CHO1, annexin 11 also associates with tubulin, though
the annexin 11–tubulin interaction was evident at both
prometaphase and cytokinesis.
In a recent study it was noted that CHO1 is the only pro-
tein so far identified as a component of the detergent-resis-
tant midbody matrix (Matuliene and Kuriyama, 2002). Our
demonstration here that annexin 11 also remains tightly as-
sociated with the midbody after biochemical isolation con-
firms annexin 11 as the second characterized protein of this
matrix. Moreover, depletion of annexin 11 by RNAi in
A431 and HeLa cells leads to the absence of a detectable
midbody matrix at cytokinesis, showing that annexin 11 is
required for the formation of this matrix in at least two dif-
ferent human cell lines. The only other protein known to be
required for the formation of the midbody matrix is CHO1.
Thus, overexpression of a mutant form of CHO1 that is un-
able to concentrate in the midbody or a significant reduction
in the level of endogenous CHO1 by RNAi treatment both
resulted in cells furrowing normally but lacking a midbody
matrix during telophase and cytokinesis (Matuliene and
Figure 7. Cytokinesis failure and apoptosis in cells treated with annexin 11 siRNA. (A) Control A431 cells undergoing cytokinesis were 
examined by video time-lapse microscopy (see Video 1). The two dividing cells are marked by red arrowheads at time 0, and the midbody is 
at the center of the red circle. By 80 min, cytokinesis was complete and the midbody was no longer visible. (B) A431 cells were treated for 2 d 
in annexin 11 siRNA, and video time-lapse microscopy was performed on cells attempting cytokinesis (see Video 2). The cells remain connected 
by a cytoplasmic bridge that becomes increasingly narrow but is never resolved (red arrowheads). After 94 min, the cells had shrunk and 
rounded up. They subsequently detached and drifted out of the field of view (not depicted). (C) A431 cells were treated with annexin 11 siRNA 
and examined for changes in cell size/shape by flow cytometry. The arrow indicates an increase in forward scatter (indicating increased cell 
length) at days two and three, which subsequently diminishes by day four. (D) A431 cells were treated for 3 d with annexin 11 siRNA or with 
oligofectamine alone as a control, and total cell lysates were resolved by SDS-PAGE and immunoblotted for PARP. Note the 85-kD band 
corresponding to the cleavage product of PARP in annexin 11–depleted cells. (E and F) HeLa cells were treated with annexin 5 siRNA (control, E) 
or annexin 11 siRNA (F) for indicated periods and analyzed by flow cytometry. Note that the sub-2n (apoptotic) peak increases substantially 
during days five and six for annexin 11 siRNA-treated cells compared with the control. The inset graph (F) provides numerical representation 
of the FACS® data. (G) A431 cells were treated with annexin 11 siRNA for 4 d and examined by flow cytometry. The inset shows cells treated 
with oligofectamine alone as a control. Note the sub-2n (apoptotic) peak present in annexin 11–depleted cells but absent in the control.
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Kuriyama, 2002). However, complete depletion of CHO1
by RNAi also caused disorganization of the central spindle
microtubule bundles, indicating a dual function for CHO1
in cytokinesis, both in the formation of a midbody matrix
and in the maintenance of the central spindle organization.
This last phenotype was not observed in annexin 11–
depleted cells, implying that the function of annexin 11 in cy-
tokinesis is linked exclusively to the formation of a midbody
matrix and completion of the terminal phase of cytokinesis.
Significantly, failure to form a midbody as a result of an-
nexin 11 depletion led to mislocalization of CHO1. Taken
with previous published work (Matuliene and Kuriyama,
2002), this finding suggests that annexin 11 and CHO1 are
both indispensable for midbody formation, supporting the
idea that the two proteins are in some way functionally
linked.
In cells treated with siRNA specific for annexin 11, the
last stage of cytokinesis is highly impaired, with daughter
cells entering interphase while still connected by abnormal
cytoplasmic bridges that they are unable to resolve, and
eventually undergoing cell death by apoptosis. Although in
most reported examples of failed cytokinesis, furrow regres-
sion and cell binucleation occur before cell death, there are a
few instances of abortive cytokinesis in which daughter cells
remain connected by bridgelike cytoplasmic structures.
These instances include overexpression of a mutant form of
CHO1 (Matuliene and Kuriyama, 2002); siRNA-mediated
depletion of centriolin (Gromley et al., 2003); overexpres-
sion of the Rho inhibitory domain of Nir2, a RhoA-binding
protein that associates with the small GTPase in the cleavage
furrow (Litvak et al., 2002); cells transfected with a mutant
form of the type III intermediate filament protein GFAP
lacking its Rho-kinase phosphorylation sites (Yasui et al.,
1998); and the blockage of phosphatidylethanolamine trans-
location at the cleavage furrow (Emoto and Umeda, 2000),
which inhibits disassembly of the actomyosin constriction
ring. These studies collectively define a subset of midbody
proteins that, like annexin 11, are likely to be functionally
coordinated to execute the final stages of cytokinesis.
The discovery of an essential role for annexin 11 in cell di-
vision is unexpected when considered in the broader context
of annexin biology. Although annexins are now firmly im-
plicated in various cellular activities, including endocytosis,
calcium signaling, and apoptosis, no member of this protein
family has been demonstrated to function in the cell cycle.
The membrane binding and vesicle fusogenic properties that
define annexins in biochemical terms could provide clues as
to the possible role of annexin 11 in the last stage of cytoki-
nesis. Before cells can be completely separated in a process
known as abscission, the actomyosin constriction ring at the
cleavage furrow has to be disassembled and the central spin-
dle must separate. During this series of events, it is likely
that the plasma membrane must be tightly attached to the
midbody microtubules for abscission to be successfully com-
pleted. CHO1 has previously been suggested to be responsi-
ble for this connection (Kuriyama et al., 2002), but there is
no evidence that this kinesin is able to bind to the cell mem-
brane. The role of annexin 11 could be to facilitate this in-
teraction. Alternatively, annexin 11 could be involved in the
vesicle fusion process that mediates the insertion of new
membrane at the cleavage furrow, which is widely estab-
lished as a key requirement for completion of cytokinesis
(Straight and Field, 2000), or it may have a role in the rear-
rangement of membrane phospholipids at the cleavage fur-
row, which is known to be crucial for the disassembly of the
actomyosin constriction ring (Emoto and Umeda, 2000). In
mammalian cells the origin of the membrane or vesicular
material that is inserted at the cleavage furrow has not been
formally identified. In 
 
Drosophila
 
 
 
melanogaster
 
, it has been
reported that Golgi-derived membrane is required for fur-
row formation during cellularization (Sisson et al., 2000),
and Golgi-associated proteins such as Arf1 (Altan-Bonnet et
al., 2003) and syntaxin 5 (Xu et al., 2002) have been shown
to have roles in cytokinesis. Here, we found no evidence of
annexin 11 association with Golgi-derived vesicles, suggest-
ing that annexin 11 is more likely to be involved in mem-
brane dynamics at the cleavage furrow than in vesicle trans-
port to this site.
In this context, it is interesting to note that annexin 11 is
not expressed in invertebrates, and is therefore absent in the
two experimental models most used for the study of cytoki-
nesis, namely 
 
D. melanogaster 
 
and 
 
C. elegans
 
. It is possible
that unrelated annexins present in these organisms fill this
function, or it may be that the role of annexin 11 in cytoki-
nesis is performed by other proteins in simpler eukaryotes.
 
Materials and methods
 
Cell lines and culture conditions
 
Human A431, HeLa, and HEp2 cells were grown in DME (GIBCO BRL)
supplemented with 10% (vol/vol) FCS, 100 U/ml penicillin, 100 
 

 
g/ml
streptomycin, and 292 
 

 
g/ml 
 
L
 
-glutamine at 37
 

 
C in 5% CO
 
2
 
 humidified
incubators. Cells were kept subconfluent, and the medium was changed
every 2 to 3 d. For microscopy, cells were plated onto sterilized coverslips
or grown in 35-mm glass bottom microwell dishes (MatTek).
 
Antibodies
 
Antibodies used for immunofluorescence were L-19 goat polyclonal anti–
human annexin 11 (Santa Cruz Biotechnology, Inc.), mouse monoclonal
anti–mouse annexin 11 (BD Biosciences), mouse monoclonal anti–
chicken 
 

 
-tubulin (Zymed Laboratories), rabbit polyclonal anti–human
 

 
-tubulin (gift of K. Matter, Institute of Ophthalmology, University College
London, London, UK), E18 rabbit polyclonal anti–chicken CHO1 (gift of R.
Kuriyama, University of Minnesota, Minneapolis, MN; Kuriyama et al.,
2002), mouse monoclonal anti–rat Aim-1 (BD Biosciences), N-19 rabbit
polyclonal anti-MKLP1 (Santa Cruz Biotechnology, Inc.), E-15 goat poly-
clonal anti-ARK-2 (Santa Cruz Biotechnology, Inc.), and M-20 goat poly-
clonal anti–mouse lamin B (Santa Cruz Biotechnology, Inc.). Secondary
antibodies were donkey anti-goat-Alexa Fluor 488 (Molecular Probes),
goat anti–mouse-Alexa Fluor 488 (Molecular Probes), donkey anti–mouse-
Alexa Fluor 488 (Molecular Probes), donkey anti–rabbit-Cy5, donkey anti–
mouse-Cy5, and donkey anti–mouse-TRITC. Antibodies used for Western
blotting were as for CHO1, L-19 goat polyclonal anti–human annexin 11
(Santa Cruz Biotechnology, Inc.), sheep polyclonal anti–chicken annexin
11 (raised against full-length recombinant chicken annexin 11), mouse
monoclonal anti–chicken 
 

 
-tubulin (Zymed Laboratories), mouse mono-
clonal anti–
 

 
-tubulin (Sigma-Aldrich), and rabbit polyclonal anti–human
PARP (Santa Cruz Biotechnology, Inc.). Antisera to annexins 1 and 5 have
been described previously (Hawkins et al., 1999).
 
Cell synchronization and isolation of midbodies
 
Cells were grown to 50% confluence and incubated in medium containing
4 mM thymidine (Sigma-Aldrich) overnight to achieve S phase block.
Dishes were extensively washed in PBS and cultured for a further 6 h in
medium containing 0.07 
 

 
g/ml nocodazole (Sigma-Aldrich) for growth ar-
rest at prometaphase. Cells were extensively washed and allowed to re-
cover in normal medium for 30–60 min or incubated for 45 min in the
presence of 15 
 

 
g/ml BFA (Sigma-Aldrich). For midbody isolation, cells
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were synchronized at prometaphase and spindles were prepared as de-
scribed previously (Kuriyama et al., 1984).
 
Fluorescence microscopy
 
Cells grown on coverslips or in 35-mm glass bottom microwell dishes
were washed in PBS, fixed/permeabilized on ice for 30 min in 2% PFA 
 

 
0.1% Triton X-100, washed four times in PBS, and blocked for 15 min with
1% BSA (Sigma-Aldrich). Fixed cells were incubated in a moist chamber
with primary antibody dissolved in 1% BSA for 1 h, followed by four
washes of 5–10 min each in PBS before incubation with the secondary an-
tibody dissolved in 1% BSA for another hour. After four further washes in
PBS, samples were either observed immediately in PBS or mounted onto
slides with Moviol and sealed with nail polish. Stained cells were observed
under a Radiance 2000 AGR-3 (Q) confocal (Bio-Rad Laboratories) at-
tached to an inverted microscope (model Axiovert S100TV; Carl Zeiss Mi-
croImaging, Inc.) using 60
 

 
 or 100
 

 
 oil immersion lenses, and images
were processed using Metamorph 4.6r9.
 
Electron microscopy
 
A431 cells were cultured on thermanox coverslips (Agar Scientific) and, af-
ter annexin 11 depletion, were fixed, processed, and treated with tannic
acid as described by Stinchcombe et al. (1995). Coverslips were mounted
on Epon stubs, the Epon polymerized overnight at 60
 

 
C, and the coverslips
removed by heating. 70-nm sections were cut en face and stained with
lead citrate before examination in a JEOL 1010 electron microscope.
 
Video time-lapse microscopy
 
A431 cells were placed in a 37
 

 
C preheated microscope chamber with 5%
CO
 
2
 
 supply and observed using phase illumination on an inverted micro-
scope (model Axiovert S100M; Carl Zeiss MicroImaging, Inc.) using a 40
 

 
oil immersion lens. Images were acquired with Openlab (Improvision) and
analyzed using Metamorph 4.6r9 (Universal Imaging Corp.).
 
Immunoprecipitation, SDS-PAGE, and Western blotting
 
A431 cell monolayers were washed in PBS, resuspended in 500 
 

 
l lysis
buffer (50 mM Tris-Cl, pH 7.4, 50 mM NaCl, 30 mM sodium pyrophos-
phate, 50 mM sodium fluoride, 100 
 

 
M sodium orthovanadate, 0.2 mM
CaCl
 
2
 
, 1% Triton X-100, 0.1% BSA, and 0.02% sodium azide) supple-
mented with 10 
 

 
l of protease inhibitor cocktail (Sigma-Aldrich) per 10
 
7
 
cells, and lysed by three rounds of sonication on ice. Lysates were pre-
cleared at 16,000 
 
g
 
 for 30 min at 4
 

 
C, followed by incubation with 30 
 

 
l
of 50% protein G–Sepharose 4 Fast Flow slurry (Amersham Biosciences)
for 30 min, and then 5 min centrifugation at 16,000 
 
g 
 
at 4
 

 
C. L-19 goat
anti–human annexin 11 antibody (Santa Cruz Biotechnology, Inc.) was im-
mobilized on protein G–Sepharose beads and added to the precleared ly-
sates for 2 h at 4
 

 
C, centrifuged, and the supernatant discarded. Beads
were washed four times in lysis buffer minus BSA and once in ice-cold
PBS. After removal of the supernatant, the immunoprecipitates were resus-
pended in SDS-PAGE sample buffer, boiled for 5 min, and resolved by
SDS-PAGE on discontinuous mini-gels. Proteins were electroblotted for 45
min at 400 mA onto Hybond-P PVDF Transfer Membrane (Amersham
Biosciences).
Membranes were treated with blocking solution (10% skimmed milk or
10% BSA in PBS-Tween [PBS 
 

 
 0.05% Tween 20]) for 40 min at RT and
incubated for 16 h at 4
 

 
C with primary antibody in PBS-Tween. After three
PBS-Tween washes, membranes were incubated with secondary antibody
for 90 min, also in PBS-Tween (1/10,000 dilution). IgG-HRP conjugates
were used as secondary antibodies. Blots were developed after three fur-
ther PBS-Tween washes using the ECL Plus Western blotting detection sys-
tem (Amersham Biosciences) and visualized in a Fujifilm Intelligent Dark
Box II coupled to a LAS-1000 CCD camera.
 
Depletion of annexin 11 in HeLa and A431 cells by RNAi
 
Preparation of siRNA oligonucleotides was performed as follows. A search
was performed for AA(N19)TT sequences with 
 

 
50% G/C-content in hu-
man annexin 11 cDNA. One such sequence was located at nt 727 in the
coding sequence. Sense (5
 

 
-gACggCUUACggCAAggAUdTdT-3
 

 
) and anti-
sense (5
 

 
-AUCCUUgCCgUAAgCCgUCdTdT-3
 

 
) siRNA oligonucleotides
were purchased from Dharmacon Research, Inc. Oligonucleotides were
diluted with 1 ml of RNase-free water to a concentration of 50 
 

 
M and an-
nealed by combining 30 
 

 
l of each with 15 
 

 
l of 5
 

 
 annealing buffer
(Dharmacon Research, Inc.). The solution was incubated at 90
 

 
C for 1 min
followed by 1 h at 37
 

 
C. The final concentration of the siRNA duplex was
20 
 

 
M.
Transfection of cells with siRNA was performed as follows. Cells were
seeded on 24-well plates in normal medium without antibiotics and trans-
fected at 30 to 40% confluency as follows. For each well, 3 
 

 
l Oligo-
fectamine reagent (Invitrogen) was dissolved in 12 
 

 
l Opti-MEM I medium
(Invitrogen), and 3–5 
 
l of siRNA duplex was added to 50 l of Opti-MEM
I medium. The solutions were incubated for 10 min at RT, combined, and
mixed by inversion. The mixture was incubated for 25 min at RT, and 30–
32 l of Opti-MEM I medium was added to bring the final volume to 100
l. The complexes were added to the cells for 1 to 3 d before analysis by
FACS®, immunofluorescence, or Western blotting. In some experiments, to
further increase the depletion of annexin 11, transfected cells were split af-
ter 3 d and retransfected as aforementioned.
Fluorescence-activated cell sorting
To determine the level of apoptosis caused by annexin 11 depletion,
siRNA-treated cells were analyzed by FACS®. Cells were collected,
washed in PBS, fixed for 30 min in 70% ethanol at 	20C, centrifuged at
560 g for 5 min at 4C, washed in PBS, and resuspended in 100 l of 1 mg/
ml RNase I-A (Sigma-Aldrich) solution in PBS for 30 min. To stain the
DNA, 150 l of propidium iodide solution (50 g/ml propidium iodide
[Sigma-Aldrich], 0.1% sodium citrate, and 0.1% Triton X-100) was added
to this preparation. Samples were processed using a FACscan™ flowcy-
tometer (BD Biosciences), and the results were analyzed with Win-
MDI 2.8.
Online supplemental material
Two supplemental figures are available showing the localization of an-
nexin 11 and the Golgi marker GM130 in A431 cells undergoing cytokine-
sis and the localization of MKLP1 and Aurora B in annexin 11–depleted
A431 cells undergoing cytokinesis. Videos showing control and annexin
11–depleted cells failing to complete cytokinesis are available as supple-
ments to Fig. 7. Note that in Video 2 the apoptosing cells detach from the
plate after the final frame. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.200311054/DC1.
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